# Pyruvate Kinase Isoform M2 (PKM2) as a Possible Biomarker for Cancer

> **NCT01130584** · — · COMPLETED · sponsor: **National University Hospital, Singapore**

## Conditions studied

- Cancer

## Interventions

- **OTHER:** Pyruvate kinase isoform M2

## Key facts

- **NCT ID:** NCT01130584
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** — (—)
- **Last updated:** 2013-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01130584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01130584, "Pyruvate Kinase Isoform M2 (PKM2) as a Possible Biomarker for Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01130584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*